StephenTillesMD
Allergy & Immunology • Seattle, WAAsthma & Allergic Conditions
Partner, Northwest Asthma and Allergy Center; Executive Director,ASTHMA Inc. Clinical research Center
Dr. Tilles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1959 NE Pacific St.
Seattle, WA 98195Phone+1 206-598-4615- Is this information wrong?
Education & Training
University of Colorado School of Medicine/National Jewish Health (Adult)Fellowship, Allergy and Immunology, 1993 - 1995
Oregon Health & Science UniversityResidency, Internal Medicine, 1990 - 1993
University of California San Diego School of MedicineClass of 1990
Certifications & Licensure
OR State Medical License 1991 - Present
CA State Medical License 1992 - Present
WA State Medical License 2000 - 2025
CO State Medical License 1994 - 1995- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
- Super Doctor SuperDoctors.com
Clinical Trials
- Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. Start of enrollment: 2002 Sep 01
- Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma Start of enrollment: 2012 Oct 01
- Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy Start of enrollment: 2015 Mar 03
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsEffects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial.Jonathan Corren, David Larson, Matthew C Altman, R Max Segnitz, Pedro C Avila, Paul A Greenberger, Fuad Baroody, Mark H Moss, Harold Nelson, Allison J Burbank, Michell...> ;The Journal of Allergy and Clinical Immunology. 2023 Jan 1
- 1 citationsUnique basophil microRNA signature in chronic spontaneous urticaria patients who respond to omalizumab.Taha Al-Shaikhly, James W. MacDonald, Theo K. Bammler, Matthew C. Altman, Andrew G. Ayars, Daniel Petroni, Stephen A. Tilles, William R. Henderson> ;Clinical and Experimental Allergy. 2021 Sep 20
- 3 citationsExtracellular vesicle microRNAs as predictors of response to omalizumab in chronic spontaneous urticariaTaha Al-Shaikhly, James W. MacDonald, Theo K. Bammler, Matthew C. Altman, Andrew G. Ayars, Daniel Petroni, Stephen A. Tilles, William R. Henderson> ;Allergy. 2021 Apr 1
- Join now to see all
Journal Articles
- Foreword Drug Hypersensitivity: Broadening HorizonsStephen Tilles, MD, ScienceDirect
Press Mentions
Aimmune Presents New Clinical Data from Pooled Safety Analysis in Patients Treated with PALFORZIA® for up to ~3.5 YearsFebruary 25th, 2021- Peanut Allergy Treatment 'In Sight'November 18th, 2019
Aimmune Therapeutics Discusses AR101’S Cost-Effectiveness and Demonstrated Clinical Benefits at ICER MeetingJune 11th, 2019- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
EvergreenHealthKirkland, Washington
Seattle Children's HospitalSeattle, Washington
UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
